Dengvaxia, a lethal vaccine in the Philippines?


What are the key takeaways for developing countries from introduction of a dangerous vaccine, developed by the French laboratory Sanofi, against dengue fever?

  • €16,760 Budget in Euros
  • 2018 Final release date
  • 1 Round winner
  • 2 Locations
  • 3 Durations in months

In 2015, the French laboratory Sanofi launched a vaccine against dengue fever - a world premiere. But soon the safety of the vaccine was put to question by the suspicious deaths of several children in the Philippines. Sanofi has evaluated the results and admitted the potential dangers of the vaccine Dengvaxia, while families claim they have been used as test subjects. However, this scandal could spark the development of better vaccines and safer practices regarding precaution and vaccination in developing countries.

image gallery

Click on any photo to view the image gallery lightbox at fullscreen.

Follow us and join the conversation